Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enteric vaccines.

R Edelman1, M M Levine

  • 1Division of Geographic Medicine, University of Maryland, School of Medicine, Baltimore 21201.

Maryland Medical Journal (Baltimore, Md. : 1985)
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Significant advancements in gastrointestinal vaccines are emerging, with new oral typhoid and cholera vaccines nearing availability. Ongoing research targets Shigella, E. coli, and rotavirus, promising future innovations in infectious disease prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with typical enteropathogenic <i>Escherichia coli</i> infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012.

Epidemiology and infection·2020
Same author

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Vaccine·2019
Same author

Diarrhoea, enteric pathogen detection and nutritional indicators among controls in the Global Enteric Multicenter Study, Kenya site: an opportunity to understand reference populations in case-control studies of diarrhoea.

Epidemiology and infection·2018
Same author

Overexpression of O-polysaccharide chain length regulators in Gram-negative bacteria using the Wzx-/Wzy-dependent pathway enhances production of defined modal length O-polysaccharide polymers for use as haptens in glycoconjugate vaccines.

Journal of applied microbiology·2018
Same author

Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activity.

Lipids·2016
Same author

Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.

Mucosal immunology·2015
Same journal

Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Seroprevalence study of Hantavirus infection in the community based population.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Pneumomediastinum: the Valsalva crunch.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Hepatic hydrothorax: diagnosis and management. Case report and review of the literature.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

A case of post-streptococcal reactive arthritis.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Sexual practices of older adults in a high HIV prevalence environment.

Maryland medical journal (Baltimore, Md. : 1985)·2000
See all related articles

Area of Science:

  • * Vaccinology and infectious disease research.
  • * Gastrointestinal health and microbial pathogenesis.
  • * Translational medicine and clinical immunology.

Background:

  • * The past decade has seen substantial progress in vaccine development for major bacterial and viral gastrointestinal infections.
  • * The Center for Vaccine Development (CVD) has been instrumental in advancing these vaccine candidates from laboratory development through clinical testing.
  • * Key targets include typhoid, cholera, Shigella, enterotoxigenic E. coli, and rotavirus.

Purpose of the Study:

  • * To review the progress in developing vaccines for critical gastrointestinal infections.
  • * To highlight the role of the Center for Vaccine Development (CVD) in this field.
  • * To discuss future directions and potential of novel vaccine candidates.

Related Experiment Videos

Main Methods:

  • * Review of vaccine development and clinical trial data for gastrointestinal pathogens.
  • * Laboratory research and development of novel vaccine platforms.
  • * Clinical testing of vaccine candidates in diverse populations.

Main Results:

  • * A new oral typhoid vaccine (Ty21a) is now licensed in the United States.
  • * A genetically engineered live oral cholera vaccine developed at CVD is in clinical trials.
  • * Multiple vaccine candidates for Shigella, enterotoxigenic E. coli, and rotavirus are undergoing clinical evaluation globally.

Conclusions:

  • * Significant strides have been made in creating vaccines against common gastrointestinal infections.
  • * Continued advances in molecular biology and immunology are expected to yield further vaccine candidates.
  • * The CVD is positioned to lead future developments in gastrointestinal vaccine technology.